Lab Medicine Rounds Reversal of DOACs: Making critical advancements
Timestamps:
00:00 Intro
00:43 Why is it important for physicians to understand about the reversal of these direct oral anticoagulants?
03:09 The complications or the bleed rate was a lot less, with these direct oral anticoagulants?
03:57 Although there is less severe bleeding, there was a concern by patients and physicians about, if it is severe, what is the plan?
04:51 What have we learned new? Are we learning more about what patient population to use them in, as well as the plans to reverse them?
06:10 Can you elaborate a little bit about the idea for weekly monitoring for INR, why is it a big deal?
7:44 Could you give us an example of where it wouldn’t be ideal to do home INR monitoring for a given patient?
09:06 Are there updates to what the reversal plans are, and how have they changed recently?
12:34 Are there still some challenges that remain for reversing these direct oral anticoagulants?
19:54 What do you think the future looks like for anticoagulant reversal?
23:47 Outro
Resources: